[Causal therapeutic management of aplastic anaemia (author's transl)].
Aplastic anaemia is characterized by hypoplasia of haemopoietic tissue. The aetiology of aplastic anaemia is multifactorial, the majority of cases being termed "idiopathic" because of lack of discernible noxious agents. Treatment can include stimulation of haemopoietic stem cells or replacement of stem cells by bone marrow transplantation. Some cases show autoimmune-mediated marrow failure and these patients may respond to immunosuppressive therapy. Pathophysiological subclassification of individual cases is necessary to ensure the correct choice of therapy offering the best chance of success, at minimum risk, from amongst a multitude of therapeutic procedures.
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000741:Anemia, Aplastic / Q000209:etiology / Q000628:therapy*; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D016026:Bone Marrow Transplantation; D006801:Humans; D045165:Testosterone Congeners / Q000627:therapeutic use; D014185:Transplantation, Isogeneic
D000305:Adrenal Cortex Hormones; D000961:Antilymphocyte Serum; D045165:Testosterone Congeners
Kausale Therapiemöglichkeiten der aplastischen Anämie.